Review of dengue virus and the development of a vaccine

S Murrell, SC Wu, M Butler - Biotechnology advances, 2011 - Elsevier
Dengue viral infection has become an increasing global health concern with over two-fifths
of the world's population at risk of infection. It is the most rapidly spreading vector borne …

Recent developments in recombinant protein–based dengue vaccines

NK Tripathi, A Shrivastava - Frontiers in immunology, 2018 - frontiersin.org
Recombinant proteins are gaining enormous importance these days due to their wide
application as biopharmaceutical products and proven safety record. Various recombinant …

[HTML][HTML] Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody

W Wahala, AA Kraus, LB Haymore, MA Accavitti-Loper… - Virology, 2009 - Elsevier
Dengue viruses (DENV) are the etiological agents of dengue fever (DF) and dengue
hemorrhagic fever (DHF). The DENV complex consists of four closely related viruses …

Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization

JH Chávez, JR Silva, AA Amarilla, LTM Figueiredo - Biologicals, 2010 - Elsevier
The Flavivirus genus of the Flaviviridae family includes 70 enveloped single-stranded-RNA
positive-sense viruses transmitted by arthropods. Among these viruses, there are a relevant …

Next generation dengue vaccines: a review of candidates in preclinical development

J Schmitz, J Roehrig, A Barrett, J Hombach - Vaccine, 2011 - Elsevier
Dengue represents a major public health problem of growing global importance. In the
absence of specific dengue therapeutics, strategies for disease control have increasingly …

Understanding the dengue viruses and progress towards their control

R Rodriguez-Roche, EA Gould - BioMed research international, 2013 - Wiley Online Library
Traditionally, the four dengue virus serotypes have been associated with fever, rash, and the
more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as …

Domain III of the envelope protein as a dengue vaccine target

MG Guzman, L Hermida, L Bernardo… - Expert review of …, 2010 - Taylor & Francis
A dengue vaccine should induce long-lasting, simultaneous protection to the four dengue
viruses while avoiding the immune enhancement of viral infection. Domain III of the dengue …

Mammalian animal models for dengue virus infection: a recent overview

MEH Kayesh, K Tsukiyama-Kohara - Archives of virology, 2022 - Springer
Dengue, a rapidly spreading mosquito-borne human viral disease caused by dengue virus
(DENV), is a public health concern in tropical and subtropical areas due to its expanding …

Dengue viruses and promising envelope protein domain III-based vaccines

H Fahimi, M Mohammadipour… - Applied microbiology …, 2018 - Springer
Dengue viruses are emerging mosquito-borne pathogens belonging to Flaviviridae family
which are transmitted to humans via the bites of infected mosquitoes Aedes aegypti and …

An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced …

LJ White, CA Sariol, MD Mattocks… - Journal of …, 2013 - Am Soc Microbiol
Despite many years of research, a dengue vaccine is not available, and the more advanced
live attenuated vaccine candidate in clinical trials requires multiple immunizations with long …